{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:17:41Z","timestamp":1792700261198,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL148071"],"award-info":[{"award-number":["HL148071"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL107653HL170157-02"],"award-info":[{"award-number":["HL107653HL170157-02"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL172741"],"award-info":[{"award-number":["P01HL172741"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL155431"],"award-info":[{"award-number":["HL155431"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jlr.2026.101003","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:48:28Z","timestamp":1771433308000},"page":"101003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2V617F mice"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-3494","authenticated-orcid":false,"given":"Brian D.","family":"Hardaway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor P.","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Tavallaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3423-7159","authenticated-orcid":false,"given":"Cheng-Chieh","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schiavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-4650","authenticated-orcid":false,"given":"Tong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-4483","authenticated-orcid":false,"given":"Ranran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Tall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2026.101003_bib1","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"Heart disease and stroke statistics: a report of US and global data from the American heart association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101003_bib2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCULATIONAHA.117.032318","article-title":"Triglyceride-rich lipoprotein cholesterol and risk of cardiovascular events among patients receiving statin therapy in the TNT trial","volume":"138","author":"Vallejo-Vaz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101003_bib3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"IMPROVE-IT investigators. Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"LoDoCo2 trial investigators. Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib6","series-title":"Drug approval package: lodoco (colchicine) tablets, 0.5 mg. Approval letter","year":"2023"},{"key":"10.1016\/j.jlr.2026.101003_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS trial group. Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100534","article-title":"Cholesterol trafficking to the ER leads to the activation of CaMKII\/JNK\/NLRP3 and promotes atherosclerosis","volume":"65","author":"Yalcinkaya","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101003_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101003_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cvr\/cvac189","article-title":"Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1\u03b2 secretion","volume":"119","author":"Yalcinkaya","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jlr.2026.101003_bib13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","article-title":"Efferocytosis induces macrophage proliferation to help resolve tissue injury","volume":"33","author":"Gerlach","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2026.101003_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","article-title":"Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury","volume":"31","author":"Yurdagul","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2026.101003_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/ATVBAHA.124.320800","article-title":"IL-1\u03b2 inhibition partially negates the beneficial effects of diet-induced atherosclerosis regression in mice","volume":"44","author":"Karnewar","year":"2024","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2026.101003_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s44161-023-00405-9","article-title":"Suppression of IL-1\u03b2 promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis","volume":"3","author":"Fidler","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.119.316461","article-title":"Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression","volume":"127","author":"Sharma","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCRESAHA.121.320296","article-title":"Targeted suppression of miRNA-33 using pHLIP improves atherosclerosis regression","volume":"131","author":"Zhang","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCRESAHA.117.311361","article-title":"Novel reversible model of atherosclerosis and regression using oligonucleotide regulation of the LDL receptor","volume":"122","author":"Basu","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s44161-021-00015-3","article-title":"Clonal hematopoiesis in cardiovascular disease and therapeutic implications","volume":"1","author":"Tall","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.jlr.2026.101003_bib21","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200 453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2026.101003_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2026.101003_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","volume":"134","author":"Cordua","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2026.101003_bib26","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/eurheartj\/ehaf114","article-title":"Plaque erosion risk and JAK2 V617F variant","volume":"46","author":"Wang","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2026.101003_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132184","article-title":"The clonal hematopoiesis mutation Jak2V617F aggravates endothelial injury and thrombosis in arteries with erosion-like intimas","volume":"409","author":"Molinaro","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jlr.2026.101003_bib28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.2023022260","article-title":"Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk","volume":"143","author":"Liu","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2026.101003_bib29","article-title":"Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice","volume":"135","author":"Liu","year":"2024","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jlr.2026.101003_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2026.101003_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168597","article-title":"Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk","volume":"133","author":"Yu","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2026.101003_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jlr.2026.101003_bib33","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/CIRCULATIONAHA.120.048378","article-title":"Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human","volume":"142","author":"Pan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101003_bib34","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.123.065344","article-title":"BRCC3-mediated NLRP3 deubiquitylation promotes inflammasome activation and atherosclerosis in Tet2 clonal hematopoiesis","volume":"148","author":"Yalcinkaya","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101003_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00395-020-00838-4","article-title":"Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering","volume":"115","author":"H\u00e4rdtner","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jlr.2026.101003_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173975","article-title":"A wild-type mouse-based model for the regression of inflammation in atherosclerosis","volume":"12","author":"Peled","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2026.101003_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","article-title":"Pyroptosis: molecular mechanisms and roles in disease","volume":"35","author":"Broz","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.jlr.2026.101003_bib38","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s42255-023-00921-9","article-title":"Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair","volume":"5","author":"Ngai","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jlr.2026.101003_bib39","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","article-title":"Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution","volume":"6","author":"Sukka","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jlr.2026.101003_bib40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/ATVBAHA.124.320797","article-title":"Trem2 agonist reprograms foamy macrophages to promote atherosclerotic plaque stability \u2014 brief report","volume":"44","author":"Patterson","year":"2024","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2026.101003_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0021-9150(92)90203-S","article-title":"Ability of the LDL receptor from several animal species to recognize the human Apo B binding domain: studies with LDL from familial defective Apo B-100","volume":"93","author":"Corsini","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2026.101003_bib42","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1016\/S0021-9258(19)70270-1","article-title":"Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells: requirements for homology for receptor binding activity","volume":"255","author":"Innerarity","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2026.101003_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcell.2015.00003","article-title":"Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism","volume":"3","author":"Dubland","year":"2015","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.jlr.2026.101003_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101283","article-title":"Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress","volume":"26","author":"de Dios","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.jlr.2026.101003_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.cell.2017.09.029","article-title":"Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation","volume":"171","author":"Dang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2026.101003_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124574","article-title":"Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression","volume":"4","author":"Lin","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jlr.2026.101003_bib47","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1172\/JCI38911","article-title":"LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression","volume":"120","author":"Feig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2026.101003_bib48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycaemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2026.101003_bib49","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2026.101003_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/cells8040328","article-title":"Circulating cell-free mtDNA contributes to AIM2 inflammasome-mediated chronic inflammation in patients with type 2 diabetes","volume":"8","author":"Bae","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2026.101003_bib51","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1182\/blood.2019000162","article-title":"JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms","volume":"134","author":"Rao","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2026.101003_bib52","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","article-title":"c-Myc and cancer metabolism","volume":"18","author":"Miller","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jlr.2026.101003_bib53","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2026.101003_bib54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/ATVBAHA.122.317583","article-title":"Myeloid LXR (liver X receptor) deficiency induces inflammatory gene expression in foamy macrophages and accelerates atherosclerosis","volume":"42","author":"Endo-Umeda","year":"2022","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2026.101003_bib55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","article-title":"Life histories of myeloproliferative neoplasms inferred from phylogenies","volume":"602","author":"Williams","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2026.101003_bib56","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/bloodadvances.2017007047","article-title":"JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics","volume":"1","author":"McKerrell","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.jlr.2026.101003_bib57","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3324\/haematol.2014.107631","article-title":"JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate","volume":"99","author":"Nielsen","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jlr.2026.101003_bib58","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.101003_bib59","doi-asserted-by":"crossref","first-page":"18889","DOI":"10.1002\/cam4.6528","article-title":"Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia","volume":"12","author":"Podoltsev","year":"2023","journal-title":"Cancer Med."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227526000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227526000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:08:34Z","timestamp":1785182914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227526000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022227526000295"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2026.101003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.23.666334","asserted-by":"object"}]},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2V617F mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2026.101003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101003"}}